rs201835496
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM1PP3BS1_Supporting
The NM_144773.4(PROKR2):āc.533G>Cā(p.Trp178Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000756 in 1,614,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_144773.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PROKR2 | ENST00000678254.1 | c.533G>C | p.Trp178Ser | missense_variant | Exon 3 of 3 | NM_144773.4 | ENSP00000504128.1 | |||
PROKR2 | ENST00000217270.4 | c.533G>C | p.Trp178Ser | missense_variant | Exon 3 of 3 | 1 | ENSP00000217270.3 | |||
PROKR2 | ENST00000678059.1 | c.425G>C | p.Trp142Ser | missense_variant | Exon 3 of 3 | ENSP00000503366.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000223 AC: 56AN: 251460Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135900
GnomAD4 exome AF: 0.0000780 AC: 114AN: 1461876Hom.: 0 Cov.: 46 AF XY: 0.0000770 AC XY: 56AN XY: 727234
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152312Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74470
ClinVar
Submissions by phenotype
Hypogonadotropic hypogonadism 3 with or without anosmia Pathogenic:2Uncertain:1Benign:1
Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as likely benign. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with Kallmann syndrome (PMID: 29161432, PMID: 18826963). (I) 0108 - This gene is associated with both recessive and dominant disease. Heterozygotes, compound heterozygotes and homozygous have all been reported and digenic inheritance is also suggested (OMIM). (I) 0112 - The condition associated with this gene has been indicated to have incomplete penetrance. Heterozygotes have been reported as asymptomatic carriers (OMIM). (I) 0200 - Variant is predicted to result in a missense amino acid change from tryptophan to serine. (I) 0251 - This variant is heterozygous. (I) 0308 - Population frequency for this variant is out of keeping with known incidence of Kallmann syndrome. The gnomAD frequency data is skewed towards the East Asian population, with 56 out of 58 global heterozygotes being observed in this subpopulation. This variant is present in 0.3% of the East Asian gnomAD population. (SB) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated 7-transmembrane receptor (NCBI_Conserved_Domains, DECIPHER, RCSB-PDB). (I) 0705 - No missense variants affecting the same amino acid have previous evidence for pathogenicity. (I) 0808 - Previous reports of pathogenicity for this variant are conflicting. This variant has been reported in Kallmann syndrome patients (PMID: 30576231, PMID: 30216942), however, it has also been reported in unaffected individuals (PMID: 30487145) and in patients with pathogenic variants in other genes (PMID: 31219235). ClinVar has conflicting interpretation of pathogenicity for this variant, however, the most recent entry is likely benign. To our knowledge, this variant has only been reported in patients from the East Asian region, a region in which this variant is present in the general population. (I) 1010 - Functional evidence for this variant is inconclusive. HEK cell functional analysis indicates that this variant may impair cell surface-targeting of the receptor (PMID: 18826963). (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
- -
- -
BS1+PS3_Moderate+PS4+PM6+PP4 -
not provided Pathogenic:1Benign:1
Identified in patients with hypogonadotropic hypogonadism or hypospadias in published literature who inherited the variant from an unaffected parent, suggesting reduced penetrance or oligogenic inheritance (Aoyama et al., 2017; Zhang et al., 2019; Zhang et al., 2021; Liu et al., 2022); Identified in patients with potentially causative variants in other genes and in one patient with a second PROKR2 variant on the opposite allele (in trans) in published literature, supporting oligogenic or recessive inheritance (Zhao et al., 2019; Zhang et al., 2019; Chen et al., 2020; Liu et al., 2022); Published functional studies demonstrate a damaging effect on transport to the plasma membrane, MAPK signaling, and mobilization of intracellular calcium (Monnier at al., 2009; Cox et al., 2018; Song et al., 2022); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed de novo without confirmed parentage in multiple unrelated patients with Kallmann syndrome or normosmic idiopathic hypogonadotropic hypogonadism in published literature (Liu et al., 2022); This variant is associated with the following publications: (PMID: 22995991, 34489640, 33120852, 34653508, 35669683, 33983622, 18559922, 36317218, 35207461, 36123965, 19707180, 34636164, 35922219, 37122876, 26088945, 24753254, 33968656, 21736917, 32155719, 21664414, 20502053, 35173048, 29161432, 18826963, 26141714, 17054399, 28915117, 30098700, 30487145, 28295047, 33208564, 31219235, 30216942, 32171629, 35090434, 30576231) -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at